author-photo

Thomas P. Davis

University of Arizona

282

Papers

12461

Citations

Citation Trend

Filter By

Papers (199) Sort By

Journal Conference Others

Transporter-Mediated Delivery of Small Molecule Drugs to the Brain: A Critical Mechanism that Can Advance Therapeutic Development for Ischemic Stroke

2020 Pharmaceutics
Show All
- Source
- Cite
- Save
Citations (13)
Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity.

2020 Journal of Cerebral Blood Flow and Metabolism
- Patrick T. Ronaldson
- Thomas P. Davis
Show All
- Source
- Cite
- Save
Citations (44)
Transport Properties of Statins by OATP1A2 and Regulation by Transforming Growth Factor-β (TGF-β) Signaling in Human Endothelial Cells.

2020 Journal of Pharmacology and Experimental Therapeutics
Show All
- Source
- Cite
- Save
Citations (2)
Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders.

2020 Frontiers in Physiology
Show All
- Source
- Cite
- Save
Citations (45)
Functional NHE1 expression is critical to blood brain barrier integrity and sumatriptan blood to brain uptake.

2020 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (2)
Vascular dysfunction—The disregarded partner of Alzheimer's disease

2019 Alzheimers & Dementia
Show All
- Source
- Cite
- Save
Citations (237)
Final Results of the RHAPSODY Trial: A Multi‐Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A‐APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke

2019 Annals of Neurology
Show All
- Source
- Cite
- Save
Citations (55)
Perivascular and Perineural Pathways Involved in Brain Delivery and Distribution of Drugs after Intranasal Administration

2019 Pharmaceutics
- Jeffrey J. Lochhead
- Thomas P. Davis
Show All
- Source
- Cite
- Save
Citations (19)
Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activ: Final Results of the RHAPSODY Trial

2019 Annals of Neurology
Show All
- Source
- Cite
- Save
Citations (0)
Loss of Blood-Brain Barrier Integrity in a KCl-Induced Model of Episodic Headache Enhances CNS Drug Delivery

2018
Show All
- Source
- Cite
- Save
Citations (15)